We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Cognitive Behavioral Therapy in OCD Highlighted by Neuropsychological Tests and MRI: Pathophysiology and Treatment Outcome Predictors

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00792038
First Posted: November 17, 2008
Last Update Posted: August 2, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
University of Aarhus
November 14, 2008
November 17, 2008
August 2, 2012
January 2009
July 2012   (Final data collection date for primary outcome measure)
Y-Bocs [ Time Frame: Before and after treatment approx 20 weeks apart ]
Same as current
Complete list of historical versions of study NCT00792038 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Effect of Cognitive Behavioral Therapy in OCD Highlighted by Neuropsychological Tests and MRI: Pathophysiology and Treatment Outcome Predictors
Effect of Cognitive Behavioral Therapy in OCD Highlighted by Neuropsychological Tests and MRI: Pathophysiology and Treatment Outcome Predictors
OCD patients are assessed before and after treatment using diagnostic tools, rating scales neuropsychological assessment and functional and structural MR-scans.
Not Provided
Observational
Observational Model: Case Control
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:
Full blood
Non-Probability Sample
OCD patients from the primary care clinics in middle Jutland, Denmark
Obsessive-Compulsive Disorder
Not Provided
  • 1
    OCD patients
  • 2
    Normal Controls
Vandborg SK, Hartmann TB, Bennedsen BE, Pedersen AD, Thomsen PH. Memory and executive functions in patients with obsessive-compulsive disorder. Cogn Behav Neurol. 2014 Mar;27(1):8-16. doi: 10.1097/WNN.0000000000000021.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
88
July 2012
July 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

1. Steady state medication 3 months prior to the study

Exclusion Criteria:

  1. History of head trauma or other organic brain disease
  2. Pregnancy.
  3. Pacemaker or other ferromagnetic materials in the body.
  4. Comorbid psychiatric illnesses assessed using SCAN- interview (30) other than moderate depression (Ham-D<17) or anxiety disorders.
  5. Antipsychotics
Sexes Eligible for Study: All
18 Years to 65 Years   (Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
Denmark
 
 
NCT00792038
M-20080161
Yes
Not Provided
Not Provided
University of Aarhus
University of Aarhus
Not Provided
Principal Investigator: Tue BH Hartmann Aarhus University Hospital, Risskov
Study Director: Sanne Kjær Aarhus University Hospital, Risskov
University of Aarhus
August 2012